Spain – Engineering services – Servicios de dirección facultativa, coordinación en seguridad y salud y asistencia técnica completa para el desarrollo de la obras del proyecto de ampliación de la fase II mediante el recrecido del viario perimetral en el depósito controlado de cola de la Mancomunidad de Gestión de Residuos del Sur en complejo ambiental La Marañosa.

Spain – Repair and maintenance services of building installations – Servicio de mantenimiento de los edificios e instalaciones de la Sociedad de Promoción Económica de Gran Canaria

Spain – Architectural, construction, engineering and inspection services – Asistencia Técnica para la maduración de la metodología y adaptación al plan BIM de la Autoridad Portuaria de Baleares

Spain – Architectural, engineering and planning services – Servicio de Asistencia Técnica para la redacción de un estudio de análisis, diagnóstico y mejora de la accesibilidad en la línea de cercanías C3 Bilbao – Orduña, y redacción del proyecto constructivo de una estación de la C3

Spain – Building and facilities management services – Servicios de explotación y mantenimiento integral de "Peiraos do Solpor"

Spain – Miscellaneous engineering services – Prestación de un servicio de asistencia técnica al Consorcio de Residuos de la Región de Murcia (COREM) para la redacción del estudio de viabilidad económico-financiera, anteproyecto, preparación de pliegos y asistencia a la mesa de contratación para la posterior concesión de una planta de valorización energética de residuos municipales en la Región de Murcia.

Spain – Exhibition, fair and congress organisation services – Servicio de asesoramiento y apoyo técnico para la organización, coordinación y desarrollo de las actividades relativas al Centenario de la Confederación Hidrográfica del Duero

The Motor Carrier Safety Assistance Program (MCSAP) is a Federal formula grant program that provides financial assistance to States, and U.S. Territories to reduce the number and severity of crashes, injuries, and fatalities and hazardous material incidents involving commercial motor vehicles.

Expected Impact: The action under this topic is expected to achieve the following impacts and contribute to the following EU policies/initiatives: deliver innovative, early technology solutions that contribute to addressing strategic unmet public health needs across multiple therapy areas to improve prevention, early diagnosis, and treatment; leverage the unique network and scale of IHI JU members to create a pipeline to support innovative startups in the health industry, fully integrated into European initiatives in support of start-ups and entrepreneurship; drive early cross-sector health R&D and innovation to strengthen the European healthcare industry’s global competitiveness, contributing to the EU Industrial Strategy and Pharmaceutical Strategy objectives; create a sustainable network of European healthcare incubators to guide and support highly talented and innovative early-stage companies; harness digital health and data-sharing technologies (e.g., AI and big data) to enable interoperable health solutions, contributing to the European Health Data Space (EHDS) and improved evidence based care;- the action should generate a portfolio of early‑stage companies that have…

Expected Impact: The action under this topic is expected to achieve the following impacts: Accelerate EU access to more cost-effective interventions in an increasingly ageing population by identifying personalised treatment approaches for elderly-onset immune diseases. Decrease disease risk later in life by defining specific prevention strategies based on ageing biomarkers and risk factors. Halt age-associated disease exacerbation by the identification of predictive and digital biomarkers that can stratify patients for early intervention. Improve quality of life for healthy individuals and patients by preventing further health decline, avoiding escalating care costs, and properly stratifying individuals earlier in the diagnostic pathway. Accelerate adoption of innovative diagnostic, preventative, and therapeutic strategies, strengthening the EU’s position as a healthcare innovator. Evaluate digital biomarker as potential regulatory endpoints in the ultimate goal to develop medicines for ‘healthy ageing’. Integrate fragmented research efforts by bringing together health industry sectors and stakeholders to develop clinical and multi-omics data integration capabilities. Enable new…

Expected Impact: The action under this topic is expected to achieve the following impacts: Faster and more informed decision-making through the use of an AI-driven NAM (AI Foundation Toxicology Model) and increased efficiency through rapid processing of vast amounts of data [1] . Increased consistency and standardisation in a NAM-based approach, specifically an AI model, used by industry in the efficient development, testing and production of safe and effective innovative health technologies, improving industrial competitiveness. Regulatory adoption of a NAM-enabled second species waiver model (AI Foundation Toxicology Model) and weight-of-evidence framework, in line with recommendations and more consistent global decision-making on waiving second species testing. Reduction in animal use, accelerated timelines and lower costs, enhancing the competitiveness of the European health industry through economical and ethical benefits. Improved public health as patients will benefit from safe and effective medicines developed faster using validated NAMs. The action is expected to contribute to the EU Directive (2010/63/EU) [2] on the protection of animals used for scientific purposes and…